Artérite temporale juvénile : une maladie bénigne

This case report suggests the potential advantages of immunoadsorption in severe Sjögren's syndrome which is refractory to conservative treatment. After 16 months the patient remains free of tender and swollen joints, and the sicca symptoms remain stable. A current open trial will provide further data, allowing better assessment of the value of immunoadsorption in patients with Sjögren's disease.

show abstract

Secondary addition of methotrexate to partial responders to etanercept alone is effective in severe rheumatoid arthritis

Cohen

2004

Annals of the Rheumatic Diseases

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Artérite temporale juvénile : une maladie bénigne

Cited by 3 publications

References 9 publications

Scalp necrosis as a manifestation of temporal arteritis

Scalp necrosis as a manifestation of temporal arteritis

Juvenile temporal arteritis and activated protein C resistance

Secondary addition of methotrexate to partial responders to etanercept alone is effective in severe rheumatoid arthritis

Contact Info

Product

Resources

About